A PHASE II AND PHARMACODYNAMIC STUDY OF GEFITINIB IN PATIENTS WITH REFRACTORY OR RECURRENT EPITHELIAL OVARIAN CANCER

PURPOSE: The primary objective of this study was to evaluate the biochemical effects of gefitinib on its target signal transduction pathways in patients with relapsed epithelial ovarian cancer (EOC). The secondary aims included assessing clinical activity and toxicity, and determining the associatio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Posadas, Edwin M., Liel, Meghan S., Kwitkowski, Virginia, Minasian, Lori, Godwin, Andrew K., Hussain, Mahrukh M., Espina, Virginia, Wood, Bradford J., Steinberg, Seth M., Kohn, Elise C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2007
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778218/
https://ncbi.nlm.nih.gov/pubmed/17330838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.22545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados